Selectis Health (GBCS) Depreciation & Amortization (CF) (2010 - 2025)

Selectis Health has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $364699.0 in Q3 2025.

• Quarterly Depreciation & Amortization (CF) fell 2.52% year-over-year to $364699.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 30.54% YoY) and the FY2025 annual result came in at $1.5 million, down 6.09% from the prior year.
• Depreciation & Amortization (CF) improved to $364699.0 in Q3 2025 per GBCS's latest filing, from $362742.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $453608.0 in Q3 2022 and troughed at $357868.0 in Q3 2023.
• A 5-year average of $413306.3 and a median of $430754.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) grew 18.21% in 2021, then dropped 21.11% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $447070.0 in 2021, then fell by 0.64% to $444195.0 in 2022, then dropped by 3.03% to $430754.0 in 2023, then declined by 15.79% to $362723.0 in 2024, then increased by 0.54% to $364699.0 in 2025.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $364699.0, $362742.0, and $363020.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.